Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions
- PMID: 6470971
- DOI: 10.1002/jps.2600730737
Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions
Abstract
Twelve fasting normal volunteers received three aspirin dosage forms in a single 325-mg dose in a complete crossover study; the plasma aspirin and salicylic acid levels and the urine salicylic acid and salicyluric acid levels were measured over 10 h. The three dosage forms included an unbuffered tablet and two effervescent solutions, one with sodium bicarbonate-citrate buffer and the other with potassium bicarbonate-citrate buffer. A significantly faster absorption rate was observed with the sodium bicarbonate-citrate buffer, when compared with the potassium bicarbonate-citrate buffer and the unbuffered tablets, which were equivalent. These differences were attributed primarily to gastric emptying rate differences. Urine pH and salicylate renal clearance were significantly affected by the single dose of antacid buffer. The area under the curve and urine accumulation comparisons suggested that approximately 25% more aspirin reaches the general circulation intact after administration of the unbuffered tablet than the two solutions, but that the total salicylate absorbed is equivalent for all three dosage forms. This difference in aspirin bioavailability is probably due to the fact that the two buffered solutions are predominantly absorbed through the intestine, in which presystemic hydrolysis occurs, whereas a significant portion of the tablet dose is absorbed through the gastric mucosa.
Similar articles
-
Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.J Pharm Sci. 1981 Mar;70(3):262-5. doi: 10.1002/jps.2600700308. J Pharm Sci. 1981. PMID: 7264888
-
Influence of food on aspirin absorption from tablets and buffered solutions.J Pharm Sci. 1983 Jul;72(7):819-21. doi: 10.1002/jps.2600720727. J Pharm Sci. 1983. PMID: 6886992
-
Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.J Pharm Sci. 1984 Sep;73(9):1258-61. doi: 10.1002/jps.2600730917. J Pharm Sci. 1984. PMID: 6491946
-
Comparative plasma salicylate and urine salicylurate levels following administration of aspirin, magnesium salicylate, and choline magnesium trisalicylate.J Pharm Sci. 1980 Nov;69(11):1355-6. doi: 10.1002/jps.2600691133. J Pharm Sci. 1980. PMID: 7452472 Clinical Trial.
-
Clinical pharmacokinetics of the salicylates.Clin Pharmacokinet. 1985 Mar-Apr;10(2):164-77. doi: 10.2165/00003088-198510020-00004. Clin Pharmacokinet. 1985. PMID: 3888490 Review.
Cited by
-
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.Infect Immun. 1993 Apr;61(4):1593-5. doi: 10.1128/iai.61.4.1593-1595.1993. Infect Immun. 1993. PMID: 8454370 Free PMC article.
-
The pharmacokinetics of aspirin in rats and the effect of buffer.J Pharmacokinet Biopharm. 1991 Apr;19(2):157-73. doi: 10.1007/BF01073867. J Pharmacokinet Biopharm. 1991. PMID: 2013838
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources